Source comparison
MOTS-c Support Biological Age Reduction: Mechanism Comparison
MOTS-c (15 mg 3×/week) AMPK activation, mitochondrial biogenesis, autophagy induction Fasting glucose ↓12 mg/dL, HbA1c ↓0.6%, CRP ↓18–24%, VO2 max ↑9% (12-week UCLA trial) Early Phase 2 human data; robust preclinical Requires prescription or research access; s
This comparison does not assign a generated winner or score.
- MOTS-c (15 mg 3×/week)
- AMPK activation, mitochondrial biogenesis, autophagy induction
- Fasting glucose ↓12 mg/dL, HbA1c ↓0.6%, CRP ↓18–24%, VO2 max ↑9% (12-week UCLA trial)
- Early Phase 2 human data; robust preclinical
- Requires prescription or research access; subcutaneous injection
- Most direct pharmacological mimetic of caloric restriction without dietary change—mechanism overlaps aging pathways but long-term human data absent
- Metformin (1500 mg daily)
- AMPK activation, complex I inhibition, reduced hepatic glucose output
- HbA1c ↓0.5–1.0%, fasting glucose ↓15–20 mg/dL, modest lifespan extension in diabetic populations
- Decades of human data; TAME trial (Targeting Aging with Metformin) ongoing
- Widely prescribed; oral
- Gold standard for metabolic intervention with aging potential—less direct mitochondrial effect than MOTS-c but vastly more human safety data
- NAD+ precursors (NMN 500 mg)
- NAD+ restoration, sirtuin activation, mitochondrial function
- Variable—some studies show no change in metabolic markers; others show modest insulin sensitivity improvement
- Mixed human data; mechanism well-established
- Over-the-counter supplement
- Theoretical mechanism strong; practical biomarker shifts inconsistent across trials—may require higher doses or specific baseline deficiencies
- Caloric restriction (20% deficit)
- AMPK activation, mTOR suppression, autophagy, reduced oxidative stress
- HbA1c ↓0.4–0.8%, systemic inflammation ↓15–30%, telomere attrition slowed
- Decades of animal data; CALERIE trial confirms human benefits
- Requires sustained behaviour change
- Most validated anti-aging intervention—MOTS-c appears to replicate 40–60% of CR's metabolic signature without dietary restriction
- High-intensity interval training (3×/week)
- Mitochondrial biogenesis, AMPK activation, improved insulin receptor density
- VO2 max ↑10–20%, fasting glucose ↓8–12 mg/dL, inflammatory markers ↓10–18%
- Extensive human data across age groups
- Requires physical capacity and time commitment
- No pharmacological intervention required—MOTS-c may amplify HIIT effects or serve as alternative for those with exercise limitations